|
Volumn 19, Issue 5, 2001, Pages 897-902
|
Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
TUMOR PROTEIN;
ADOPTIVE TRANSFER;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
BURKITT LYMPHOMA;
CELL CULTURE;
COMPARATIVE STUDY;
CYTOLOGY;
DOSE RESPONSE;
EXPERIMENTAL LEUKEMIA;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
IMMUNOLOGY;
LYMPHOMA;
MOLECULAR WEIGHT;
MORTALITY;
MOUSE;
PATHOLOGY;
SPLEEN;
SURVIVAL RATE;
WESTERN BLOTTING;
ADOPTIVE TRANSFER;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BLOTTING, WESTERN;
BURKITT LYMPHOMA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLOW CYTOMETRY;
HUMANS;
LEUKEMIA, EXPERIMENTAL;
LYMPHOMA;
MICE;
MICE, INBRED BALB C;
MOLECULAR WEIGHT;
NEOPLASM PROTEINS;
SPLEEN;
SURVIVAL RATE;
TUMOR CELLS, CULTURED;
MLCS;
MLOWN;
|
EID: 0035511705
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.19.5.897 Document Type: Article |
Times cited : (10)
|
References (0)
|